Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea · Delayed Price · Currency is KRW 6,560.00
+160.00 (2.50%)
At close: Sep 9, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 169.28 billion as of September 9, 2026. Its market cap has decreased by -26.47% in one year.
Market Cap
169.28B
Enterprise Value
176.80B
Revenue
17.39B
Ranking
n/a
PE Ratio
186.70
Stock Price
6,560.00
ChartMarket Cap Chart
Since August 20, 2018, Bio Solution's market cap has decreased from 218.31B to 169.28B, a decrease of -22.46%. That is a compound annual growth rate of -3.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 169.28B | -11.47% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 209.42B |
| Kangstem Biotech | 206.45B |
| Kanaph Therapeutics | 185.94B |
| Genome & Company | 171.80B |
| NIBEC | 168.13B |
| Ensol Biosciences | 143.76B |
| ISU Abxis | 140.47B |
| ViGenCell | 138.98B |